These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27699042)

  • 1. Simultaneous occurrence of non-Hodgkin lymphoma, renal cell carcinoma and oncocytoma: A case report.
    Zabrocka E; Sierko E; Jelski S; Wojtukiewicz MZ
    Mol Clin Oncol; 2016 Oct; 5(4):455-457. PubMed ID: 27699042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis.
    Linschoten M; Kamphuis JAM; van Rhenen A; Bosman LP; Cramer MJ; Doevendans PA; Teske AJ; Asselbergs FW
    Lancet Haematol; 2020 Apr; 7(4):e295-e308. PubMed ID: 32135128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary renal lymphoma: a clinical analysis of 5 cases].
    Lu L; Shi HZ; Xiao ZJ; Wang D; Li CL
    Zhonghua Yi Xue Za Zhi; 2018 May; 98(18):1443-1445. PubMed ID: 29804410
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary lymphoma of the kidney. Report of a case and update of the literature.
    Porcaro AB; D'Amico A; Novella G; Curti P; Ficarra V; Antoniolli SZ; Martignoni G; Matteo B; Malossini G
    Arch Ital Urol Androl; 2002 Mar; 74(1):44-7. PubMed ID: 12053451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary adrenal non-Hodgkin lymphoma: a case report and review of the literature.
    Ram N; Rashid O; Farooq S; Ulhaq I; Islam N
    J Med Case Rep; 2017 Apr; 11(1):108. PubMed ID: 28410600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical characteristics and treatment strategies for early-stage primary gastric diffuse large B-cell lymphoma].
    Qin Y; Liu P; Yang JL; Jin J; He XH; Wang WH; Fang H; Zhou SY; Zhou LQ; Song YW; Shi YK
    Zhonghua Yi Xue Za Zhi; 2018 Jun; 98(24):1945-1950. PubMed ID: 29996288
    [No Abstract]   [Full Text] [Related]  

  • 7. [Renal cell carcinoma in a patient with malignant lymphoma: a case report].
    Takagi Y; Senda M; Tanaka J
    Hinyokika Kiyo; 2000 Aug; 46(8):545-7. PubMed ID: 11019373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
    Poeschel V; Held G; Ziepert M; Witzens-Harig M; Holte H; Thurner L; Borchmann P; Viardot A; Soekler M; Keller U; Schmidt C; Truemper L; Mahlberg R; Marks R; Hoeffkes HG; Metzner B; Dierlamm J; Frickhofen N; Haenel M; Neubauer A; Kneba M; Merli F; Tucci A; de Nully Brown P; Federico M; Lengfelder E; di Rocco A; Trappe R; Rosenwald A; Berdel C; Maisenhoelder M; Shpilberg O; Amam J; Christofyllakis K; Hartmann F; Murawski N; Stilgenbauer S; Nickelsen M; Wulf G; Glass B; Schmitz N; Altmann B; Loeffler M; Pfreundschuh M; ;
    Lancet; 2019 Dec; 394(10216):2271-2281. PubMed ID: 31868632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collision Kidney Tumor Consisting of Clear Cell Renal Cell Carcinoma and Primary Renal Mantle Cell Lymphoma: A Case Report.
    Yang H; Wang P
    Arch Esp Urol; 2023 Oct; 76(8):627-632. PubMed ID: 37960962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
    Halasz LM; Jacene HA; Catalano PJ; Van den Abbeele AD; Lacasce A; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e647-54. PubMed ID: 22607911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymptomatic Giant Right Renal Oncocytoma: A Case Report.
    Çevik G; Tozsin A; Erdoğan EG; Çakıcı H; Akdere H
    Cureus; 2023 Jan; 15(1):e34129. PubMed ID: 36843740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
    Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
    Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous breast cancer and non-Hodgkin lymphoma: A case report.
    Syamsu SA; Setiady R; Smaradania N; Prihantono ; Irsandy F; Faruk M
    Int J Surg Case Rep; 2022 Aug; 97():107398. PubMed ID: 35834927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma.
    Shi Y; Zhou P; Han X; He X; Zhou S; Liu P; Yang J; Zhang C; Gui L; Qin Y; Yang S; Zhao L; Yao J; Zhang S
    Chin J Cancer; 2015 Sep; 34(11):522-30. PubMed ID: 26370464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.
    Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N
    J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
    Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
    Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of renal oncocytoma with synchronous contralateral renal cell carcinoma].
    Tsuji H; Kurita T; Tahara H; Negita M; Nagai N
    Hinyokika Kiyo; 2001 Jan; 47(1):27-9. PubMed ID: 11235217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).
    Fridrik MA; Jaeger U; Petzer A; Willenbacher W; Keil F; Lang A; Andel J; Burgstaller S; Krieger O; Oberaigner W; Sihorsch K; Greil R
    Eur J Cancer; 2016 May; 58():112-21. PubMed ID: 26990931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
    Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
    Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
    Marcus R; Hagenbeek A
    Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.